Syncor Reports Sharply Higher Profit in Quarter

Syncor International, a Chatsworth provider of specialized pharmaceutical services for doctors and hospitals, reported that its fiscal first-quarter earnings jumped 38%, to $2.2 million from $1.6 million a year earlier.

Sales in the quarter ended Aug. 31 rose 26%, to $59.6 million from $47.3 million.

Gene R. McGrevin, Syncor’s president and chief executive officer, attributed the growth in sales and earnings to two new cardiology products.